Healthcare Business International interviewed Nelson Advisors partner Lloyd Price discussing Healthbridge's acquisition of AI scribe Nora

Apr 10, 2026By Nelson Advisors

NA

Healthcare Business International interviewed Nelson Advisors partner Lloyd Price discussing Healthbridge's acquisition of AI scribe Nora.

“The acquisition highlights a broader shift in the industry, as companies are leaning more toward acquisitions instead of building everything in-house,” Lloyd Price, partner at M&A advisory firm Nelson Advisors told HBI.

From an investment perspective, the focus is on clinical AI tools that can “demonstrate productivity and efficiency gains whilst growing their user base month after month.”

“Healthtech investors are adapting fast too. AI native startups now command higher revenue multiples (typically 9×–14×) thanks to their proprietary datasets and scalable automation potential. Exit timelines are tightening as well, with many “incubation‑to‑exit” deals wrapping up in under three years,” said Price.

“Altogether, valuations are breaking away from speculative tech trends and increasingly rewarding platforms that serve as core clinical operating systems rather than optional add‑ons,” he further added. Investors are increasingly focusing on metrics such as annual recurring revenue per clinician and outcome-based pricing that reflect “tangible clinical improvements” as value creation levers.

The acquisition also highlights the rapid growth in South Africa’s healthtech market. The digital health and AI scribe market is quickly “moving from a ‘nice to have’ to an essential tool across both private and public healthcare.”

Source: https://www.healthcarebusinessinternational.com/healthbridge-buys-ai-scribe-nora/

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital 

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech

Nelson Advisors LLP

Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT

[email protected]

[email protected]

Meet Nelson Advisors @ 2026 Events

Digital Health Rewired > March 2026 > Birmingham, UK 

NHS ConfedExpo  > June 2026 > Manchester, UK 

HLTH Europe > June 2026, Amsterdam, Netherlands

HIMSS AI in Healthcare > July 2026, New York, USA

Bits & Pretzels > September 2026, Munich, Germany  

World Health Summit 2026 > October 2026, Berlin, Germany

HealthInvestor Healthcare Summit > October 2026, London, UK 

HLTH USA 2026 > October 2026, USA

Barclays Health Elevate > October 2026, London, UK 

Web Summit 2026 > November 2026, Lisbon, Portugal  

MEDICA 2026 > November 2026, Düsseldorf, Germany

Venture Capital World Summit > December 2026 Toronto, Canada